Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Pemafibrate and Tofogliflozin in Healthy Volunteers
NCT04237597Phase 1Completed
- Start
- Dec 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pemafibrate and tofogliflozin in Nonalcoholic steatohepatitis (NASH). Primary endpoint: Area under the plasma concentration versus time curve. Started Dec 2019; status: completed.
02
Drugs
pemafibratetofogliflozin
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04237597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04237597.